-
8 Of The Biggest Whistles Ever Blown On Wall Street
Monday, July 31, 2017 - 9:46am | 666Read More...Chelsea Manning, Edward Snowden, Julian Assange, Deep Throat. You know the names. Whether you consider them informants, patriots or glorified tattle-tales, whistleblowers have significantly impacted United States history. They‘ve alerted us to illegal or unethical activity in public and...
-
Theranos' Founder Owes Her Company $25 Million
Thursday, April 6, 2017 - 10:48am | 403Read More...Elizabeth Holmes, the founder of Theranos, owes her own company $25 million. This may be an issue since her net worth as of June of 2016 plummeted from $5 billion to zero. The Wall Street Journal reported Wednesday Holmes owes her failed blood testing company millions of dollars. The debt comes...
-
AirPods, Pokemon And 10 Of The Most Notable Tech Stories Of The Year
Saturday, December 31, 2016 - 3:45pm | 729Read More...Recode's Kara Swisher and The Verge's Lauren Goode took a look back at what they consider to be the top 10 technology related stories of 2016. 10. Apple's Headphone Jack Coming in at No. 10 is Apple Inc. (NASDAQ: AAPL)'s decision to say goodbye to its tangled earbuds which it...
-
Theranos Will Close Its Testing Labs And Fire 340 Workers
Thursday, October 6, 2016 - 8:12am | 336Read More...Theranos, the controversial blood-testing company, said in a blog post it will close its testing labs, fire around 340 workers and now focus on its next-generation testing device called miniLab. Theranos' blood testing device called Edison examined blood samples to identify dozens of conditions...
-
Walgreen Ends Its Shaky Relationship With Theranos
Monday, June 13, 2016 - 9:10am | 444Read More...The Wall Street Journal described Walgreens Boots Alliance Inc (NASDAQ: WBA)'s relationship with Theranos as an "extreme case study of what can go wrong" in a business relationship. Since then, Walgreens has confirmed in a press release over the weekend that its relationship with...
-
Walgreens' Relationship With Theranos 'An Extreme Case Study Of What Can Go Wrong'
Thursday, May 26, 2016 - 11:58am | 317Read More...Business textbooks looking to include a chapter on a deal gone bad should take a closer look at Walgreens Boots Alliance Inc (NASDAQ: WBA)'s partnership with Theranos Inc. Theranos is a startup company whose testing devices called Edison examine blood samples to identify dozens of conditions. What...
-
Cramer Likes Accelerate Diagnostics Inc
Sunday, April 3, 2016 - 4:45pm | 354Read More...CNBC Mad Money's Jim Cramer spoke on the show on Friday about Accelerate Diagnostics Inc (NASDAQ: AXDX). The company is developing diagnostics platform that can identify bacteria and viruses and figure out the best treatment for a patient much faster than the equipment currently used in medical...
-
Theranos On Thin Ice With Walgreens
Thursday, February 11, 2016 - 12:36pm | 301Read More...Blood-testing firm Theranos Inc. has been under the microscope in recent weeks after news broke that the company's California lab was out of compliance with federal regulations. The firm's lab was cited for several violations, one of which was said to "pose immediate jeopardy to patient health and...
-
Walgreens Begins To Back Away From Theranos
Friday, January 29, 2016 - 8:23am | 493Read More...Theranos Inc. has had a rough start to the year as the company has been struggling under the weight of accusations that its testing procedures pose a threat to patients' health and safety. This week, the Centers for Medicare & Medicaid Services released a letter saying the...
-
ICYMI: There's More Trouble For Theranos
Tuesday, January 26, 2016 - 1:56pm | 328Read More...Privately-held Theranos' lab has been under the microscope recently as the company's operations have been criticized by regulators. Earlier this year, the diagnostics lab was forced to abandon the use of its blood collection vials after the Food and Drug Administration said the devices were "...
-
Citron Reiterates $1 Target On Accelerate Diagnostics
Wednesday, January 20, 2016 - 2:23pm | 212Read More...Shares of Accelerate Diagnostics Inc (NASDAQ: AXDX) plunged to a new 52-week low of $13.78 on Wednesday after Citron Research reiterated a $1 price target on the stock. Accelerate Diagnostics is an in-vitro diagnostics company providing solutions to improve patient outcomes and lower healthcare...
